ProShares - Ultra Nasdaq Biotechnology (BIB) Options Greeks
Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.
ProShares - Ultra Nasdaq Biotechnology (BIB) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $80.0M, listed on NASDAQ, carrying a beta of 1.16 to the broader market. ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. public since 2010-04-09.
Snapshot as of May 15, 2026.
- Spot Price
- $80.60
- Net Gamma
- $13.6K
- Net Delta
- -$772.2K
- Net Vega
- -$1.6K
- ATM IV
- 47.1%
- Gamma Concentration
- 0.11
As of May 15, 2026, ProShares - Ultra Nasdaq Biotechnology (BIB) aggregate Greeks are net delta -$772.2K, net gamma $13.6K, net vega -$1.6K, ATM IV 47.1%. Gamma concentration is 0.11: gamma is more dispersed, reducing any single-strike pinning force. Delta measures directional exposure, gamma measures the rate of delta change, and vega measures sensitivity to implied volatility. Net aggregate Greeks summarize the total dealer book across all strikes and expirations.
How BIB options greeks Data Feeds Strategy Selection
Strategy selection on ProShares - Ultra Nasdaq Biotechnology options does not derive from any single metric in isolation. The options greeks view above sits inside a broader read: ATM IV currently sits at 47.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options greeks data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how options Greeks is reported and how to read the data →
Frequently asked BIB options greeks questions
- What are the BIB aggregate Greek exposures?
- As of May 15, 2026, ProShares - Ultra Nasdaq Biotechnology (BIB) snapshot Greeks are net delta -$772.2K, net gamma $13.6K, net vega -$1.6K. These aggregate the dealer book across all listed strikes and expirations under the standard customer-versus-dealer sign convention.
- What does the BIB net dealer delta tell us?
- Net dealer delta of -$772.2K represents the directional exposure dealers carry from their option inventory. Dealers continuously hedge this exposure with stock, futures, or correlated instruments, so the size of net delta is also the size of hedge flow that will execute as spot moves.
- How do BIB Greeks inform hedging?
- Delta tracks first-order directional exposure; gamma tracks how quickly delta changes; vega tracks IV sensitivity. Aggregated dealer Greeks let traders read the dealer-positioning regime: long-gamma regimes mean-revert moves; short-gamma regimes amplify them. Vega exposure indicates how dealer P&L responds to vol shocks and hence the direction of vol-shock hedging flows.